Virani SS, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–596.

Article  PubMed  Google Scholar 

McDonagh TA, et al. focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;2023.

Tyminska A, et al. Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction- clinical characteristics and prognosis depending on heart failure etiology (data from European Society of Cardiology Heart Failure Registries). Biology (Basel). 2022;11(2).

Zhu J, et al. The incidence of acute myocardial infarction in relation to overweight and obesity: a meta-analysis. Arch Med Sci. 2014;10(5):855–62.

Article  PubMed  PubMed Central  Google Scholar 

Rieckmann M, et al. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J Clin Invest. 2019;129(11):4922–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yue R, et al. NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin. Cell Death Discov. 2021;7(1):50.

Article  MathSciNet  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, et al. Excessive inflammation impairs heart regeneration in zebrafish breakdance mutant after cryoinjury. Fish Shellfish Immunol. 2019;89:117–26.

Article  CAS  PubMed  Google Scholar 

Lee JW, et al. Lysophosphatidic acid receptor 4 is transiently expressed during cardiac differentiation and critical for repair of the damaged heart. Mol Ther. 2021;29(3):1151–63.

Article  CAS  PubMed  Google Scholar 

Wang F, et al. LPA(3)-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice. Theranostics. 2020;10(24):10892–907.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, et al. Lysophosphatidic acid is associated with cardiac dysfunction and hypertrophy by suppressing autophagy via the LPA3/AKT/mTOR pathway. Front Physiol. 2018;9:1315.

Article  PubMed  PubMed Central  Google Scholar 

Wen H, et al. Higher serum lysophosphatidic acids predict left ventricular reverse remodeling in pediatric dilated cardiomyopathy. Front Pediatr. 2021;9: 710720.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Brown A, et al. Lysophosphatidic acid receptor mRNA levels in heart and white adipose tissue are associated with obesity in mice and humans. PLoS ONE. 2017;12(12): e0189402.

Article  PubMed  PubMed Central  Google Scholar 

Hait NC, Maiti A. The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer. Mediators Inflamm. 2017;2017:4806541.

Article  PubMed  PubMed Central  Google Scholar 

Berwick ML, et al. The role of ceramide 1-phosphate in inflammation, cellular proliferation, and wound healing. Adv Exp Med Biol. 2019;1159:65–77.

Article  CAS  PubMed  Google Scholar 

Geraldo LHM, et al. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct Target Ther. 2021;6(1):45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tokumura A, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 2002;277(42):39436–42.

Article  CAS  PubMed  Google Scholar 

Spohr TC, et al. LPA-primed astrocytes induce axonal outgrowth of cortical progenitors by activating PKA signaling pathways and modulating extracellular matrix proteins. Front Cell Neurosci. 2014;8:296.

Article  PubMed  PubMed Central  Google Scholar 

Fukushima N, Weiner JA, Chun J. Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. Dev Biol. 2000;228(1):6–1.

Article  CAS  PubMed  Google Scholar 

McIntyre TM, et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci USA. 2003;100(1):131–6.

Article  ADS  CAS  PubMed  Google Scholar 

Choi JW, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol. 2010;50:157–86.

Article  CAS  PubMed  Google Scholar 

Ray R, et al. Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment. Cell Commun Signal. 2020;18(1):170.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li N, et al. Lysophosphatidic acid enhances human umbilical cord mesenchymal stem cell viability without differentiation via LPA receptor mediating manner. Apoptosis. 2017;22(10):1296–309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tigyi G, et al. Revisiting the role of lysophosphatidic acid in stem cell biology. Exp Biol Med (Maywood). 2021;246(16):1802–9.

Article  CAS  PubMed  Google Scholar 

Pan X, et al. Lysophosphatidic acid may be a novel biomarker for early acute aortic dissection. Front Surg. 2021;8: 789992.

Article  PubMed  Google Scholar 

Axelsson Raja A, et al. Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model. Proc Natl Acad Sci USA. 2022;119(28): e2204174119.

Article  PubMed  PubMed Central  Google Scholar 

Wu L, et al. Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis. Osteoarthritis Cartilage. 2015;23(2):308–18.

Article  CAS  PubMed  Google Scholar 

Cao P, et al. Autocrine lysophosphatidic acid signaling activates beta-catenin and promotes lung allograft fibrosis. J Clin Invest. 2017;127(4):1517–30.

Article  PubMed  PubMed Central  Google Scholar 

Tang N, et al. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts. J Cell Mol Med. 2014;18(1):156–69.

Article  CAS  PubMed  Google Scholar 

Bot M, et al. Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation. J Lipid Res. 2013;54(5):1265–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kritikou E, et al. Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice. Sci Rep. 2016;6:37585.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Aldi S, et al. Integrated human evaluation of the lysophosphatidic acid pathway as a novel therapeutic target in atherosclerosis. Mol Ther Methods Clin Dev. 2018;10:17–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nathan S, et al. CREB-dependent LPA-induced signaling initiates a pro-fibrotic feedback loop between small airway basal cells and fibroblasts. Respir Res. 2021;22(1):97.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

• Decato BE, et al. LPA(1) antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis. Respir Res. 2022;23(1):61. Decato et al. studied the antifibrotic effects of the LPA1 antagonist BMS-986020 in idiopathic pulmonary fibrosis (IPF), a disease with limited treatment options. This research is groundbreaking because it not only highlights the potential of targeting the LPA-LPA1 pathway in IPF treatment, but also extends our understanding of the disease's mechanisms, particularly in relation to collagen turnover, that can have a therapeutic potential in number of other disease conditions where fibrosis is one of the hallmark of disease including heart failure.

Palmer SM, et al. Randomized, double-blind, placebo-controlled, phase 2 trial of BMS-986020, a lysophosphatidic acid receptor antagonist for the treatment of idiopathic pulmonary fibrosis. Chest. 2018;154(5):1061–9.

Article  PubMed  Google Scholar 

Corte TJ, et al. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). BMJ Open Respir Res. 2021;8(1).

Shu H, et al. Emerging roles of ceramide in cardiovascular diseases. Aging Dis. 2022;13(1):232–5.

Article  PubMed  PubMed Central  Google Scholar 

Mozaffarian D, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–32.

PubMed  Google Scholar 

Zouggari Y, et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. 2013;19(10):1273–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abo-Aly M, et al. Prognostic significance of activated monocytes in patients with ST-elevation myocardial infarction. Int J Mol Sci. 2023;24(14).

Maekawa Y, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol. 2002;39(2):241–6.

Article  PubMed